Endogenous opioid peptides and brain development: Endomorphin‐1 and Nociceptin play a sex‐specific role in the control of oligodendrocyte maturation and brain myelination
Abstract
The generation of fully functional oligodendrocytes, the myelinating cells of the central nervous system, is preceded by a complex maturational process. We previously showed that the timing of oligodendrocyte differentiation and rat brain myelination were altered by perinatal exposure to buprenorphine and methadone, opioid analogs used for the management of pregnant addicts. Those observations suggested the involvement of the μ‐opioid receptor (MOR) and the nociceptin/orphanin FQ receptor (NOR). However, it remained to be determined if these receptors and their endogenous ligands could indeed control the timing of myelination under normal physiological conditions of brain development. We now found that the endogenous MOR ligand endomorphin‐1 (EM‐1) exerts a striking stimulatory action on cellular and morphological maturation of rat pre‐oligodendrocytes, but unexpectedly, these effects appear to be restricted to the cells from the female pups. Critically, this stimulation is abolished by coincubation with the endogenous NOR ligand nociceptin. Furthermore, NOR antagonist treatment of 9‐day‐old female pups results in accelerated brain myelination. Interestingly, the lack of sex‐dependent differences in developmental brain levels of EM‐1 and nociceptin, or oligodendroglial expression of MOR and NOR, suggests that the observed sex‐specific responses may be highly dependent on important intrinsic differences between the male and female oligodendrocytes. The discovery of a significant effect of EM‐1 and nociceptin in the developing female oligodendrocytes and brain myelination, underscores the need for further studies investigating brain sex‐related differences and their implications in opioid use and abuse, pain control, and susceptibility and remyelinating capacity in demyelinating disease as multiple sclerosis.Keywords
Funding Information
- National Institutes of Health (NIH grants CTSA (VCU Center for Clinical and Translational Research) UL1TR00058, P30 CA016059)
- National Multiple Sclerosis Society (RG 1501‐2891)
This publication has 69 references indexed in Scilit:
- Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ‐opioid‐ and nociceptin/orphanin FQ receptors in cell development: Implications for drug addiction treatment during pregnancyGlia, 2011
- Automated Sholl analysis of digitized neuronal morphology at multiple scales: Whole cell Sholl analysis versus Sholl analysis of arbor subregionsCytometry Part A, 2010
- Mu-Opioid Receptors Transiently Activate the Akt-nNOS Pathway to Produce Sustained Potentiation of PKC-Mediated NMDAR-CaMKII SignalingPLOS ONE, 2010
- Mitogen‐activated protein kinase activated protein kinase 2 (MK2) participates in p38 MAPK regulated control of oligodendrocyte differentiationGlia, 2010
- Oligodendrocytes Changing the Rules: Action Potentials in Glia and Oligodendrocytes Controlling Action PotentialsThe Neuroscientist, 2008
- The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphineNeuroscience, 2008
- Opioid addiction and pregnancy: Perinatal exposure to buprenorphine affects myelination in the developing brainGlia, 2008
- The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaineNeuropharmacology, 2007
- Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy imagesCytometry Part A, 2004
- Myelin deficient mice: Expression of myelin basic protein and generation of mice with varying levels of myelinCell, 1987